Psychiatry and Neurology, Neurology · Foxboro, MA
NPI
1932467040
Since 2012
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
18 Washington St
Foxboro, MA, 02035
Phone (781) 551-5812
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,048 services
Medicare patients, 2024
443
Average age 71
Drug cost, 2024
$943K
4,386 prescriptions
Company payments, 2025
$990
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ozaire A Awais was code 99213 (office e&m - established), 384 times for 260 patients. In total Ozaire A Awais billed 1,048 services in 12 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 384 | 260 | $63.60 | $24K |
| 99214 Office E&M - Established | Office | 144 | 114 | $93.96 | $14K |
| 99204 Office E&M - New | Office | 110 | 110 | $119.69 | $13K |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $102.79 | $2,364 |
| 99442 Telephone Services | Office | 22 | 22 | $72.66 | $1,599 |
| 99232 Hospital E&M - Subsequent | Facility | 12 | 11 | $61.80 | $742 |
By year: 2022 $74K for 2,429 services; 2023 $58K for 770 services; 2024 $60K for 1,048 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ozaire A Awais prescribed most often to Medicare patients was Gabapentin, with 551 prescriptions and refills. In total Ozaire A Awais wrote 4,386 Medicare prescriptions that cost $943K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 551 | 743 | 114 | $6,201 |
| Memantine Hcl Generic | 312 | 494 | 67 | $13K |
| Levetiracetam Generic | 251 | 343 | 39 | $6,544 |
| Donepezil Hcl Generic | 203 | 389 | 49 | $2,037 |
| Topiramate Generic | 169 | 346 | 48 | $2,237 |
| Emgality Pen Galcanezumab-Gnlm | 166 | 166 | 30 | $123K |
| Lamotrigine Generic | 143 | 230 | 18 | $2,497 |
| Nurtec Odt Rimegepant Sulfate | 121 | 136 | 27 | $225K |
| Sumatriptan Succinate Generic | 109 | 122 | 22 | $1,104 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 101 | 107 | 30 | $1,164 |
| Divalproex Sodium Er Divalproex Sodium | 95 | 143 | 15 | $3,002 |
| Amitriptyline Hcl Generic | 91 | 147 | 22 | $1,071 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 84 | 153 | 26 | $1,546 |
| Duloxetine Hcl Generic | 78 | 134 | 25 | $2,568 |
| Tizanidine Hcl Generic | 77 | 129 | 20 | $650 |
Brand drugs: 531 claims; generic drugs: 3,813 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ozaire A Awais $990 ($990 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $154.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $154 |
| Lundbeck LLC | 2 | $154 |
| Eisai Inc. 4523.T | 2 | $119 |
| Pfizer Inc. PFE | 6 | $109 |
| EMD Serono, Inc. MRK.DE | 3 | $98.76 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $79.19 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $48.5 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $37.22 |
| Amgen Inc. AMGN | 2 | $32.32 |
| Invivyd Inc IVVD | 1 | $24.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.